News

The latest news and insights on MS.

Advertisement

FDA approves first treatment for primary progressive MS

Ocrevus clinical trials have shown significant benefits against MS relapses and progression.

Illustration showing chat bubbles.

@Momentum

Readers sound off on the African-American MS experience and finding new identities.

Asking for help

It’s not always easy to reach out and find connections.

Illustration showing chat bubbles.

@Momentum

Momentum readers sound off on resilience, spasticity and more.

Becoming more inclusive

Cyndi Zagieboylo on how the National MS Society is embracing diversity.

Illustration showing chat bubbles.

@Momentum

Readers sound off on pregnancy, mobility and more.

New hope for progressive MS breakthroughs

Promising treatments and insights are on the horizon.

Strengthening relationships

Social and professional resources can ensure people most severely affected by MS have what they… Read More

MS classifications revised

Learn how your MS is now classified—and what that might mean for treatment.

Society scholarships help fulfill dreams

Meet one young man whose Society scholarship is changing his world.

A message from Cyndi Zagieboylo: Reconnecting with our community

The National MS Society now offers more ways for people to engage than ever before.

Illustration showing chat bubbles.

Letters to the editor: Staying motivated, hope and aHSCT

Momentum readers sound off on staying motivated, remaining hopeful and the promise of aHSCT.

A message from Cyndi Zagieboylo: Connecting to information

Overhauling the National Multiple Sclerosis Society website for easier access

Illustration showing chat bubbles.

Letters to the editor: Finding the positives

Readers sound off on MS blessings, MS through the ages and staying positive.

Ed Dowd

A legacy of giving back

Ed Dowd, whose gift established the Edward M. Dowd Personal Advocate Program, passes away.

A message from Cyndi Zagieboylo: Accelerating progress

The National MS Society’s Pathways to Cures initiative aims to stop MS in its tracks

Advertisement